ScholarIQanswers from OpenAlex

COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1

PaperCitations, authors & open-access status

COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 have?

ScholarIQcitation count

COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 has 33 citations in the OpenAlex counts ScholarIQ stores.

When was COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 published?

ScholarIQyear

COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 has 2004 year in the ScholarIQ index.

What is the open-access status of COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1?

ScholarIQoa status

COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 has closed oa status in the ScholarIQ index.

What is the DOI of COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1?

ScholarIQdoi

The DOI for COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 is on the source record.

What is the PMID of COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1?

ScholarIQpmid

The PMID for COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 is on the source record.

What is the OpenAlex record for COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1?

ScholarIQopenalex

The OpenAlex for COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro1 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial